nitrendipine has been researched along with Diabetes Mellitus, Adult-Onset in 20 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Excerpt | Relevance | Reference |
---|---|---|
"A trial to study the efficacy, safety and tolerability of nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria (MA) was performed to compare the effects of both drugs in the prevention of the renal impairment." | 9.08 | Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria. ( Cases, A; Closas, J; Cobos, A; Esmatges, E; Pascual, R; Piñol, C; Planas, J; Soler, J, 1996) |
"To compare the effects of a calcium antagonist (nitrendipine) and an angiotensin converting enzyme inhibitor (enalapril) with those of placebo on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension." | 9.08 | Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension. ( Bak, AA; Gerritsen, TA; Grobbee, DE; Jonker, JJ; Stolk, RP, 1998) |
"The effect of short- (98 days) and long-term (1 year) treatment with nitrendipine (10 to 40 mg/d) and enalapril (5 to 20 mg/d) on kidney function was studied prospectively in a parallel group design in 16 microalbuminuric non-insulin-dependent diabetic patients with mild hypertension and biopsy-proven diabetic glomerulopathy." | 9.07 | Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. ( Bianchi, L; Campana, M; Cortesi, L; Mecca, G; Mosconi, L; Pagani, G; Remuzzi, G; Ruggenenti, P, 1994) |
"After a 4-week washout period, mildly hypertensive (systolic blood pressure [sBP] > or = 140 mmHg and/or diastolic blood pressure [dBP] > or = 90 mmHg) NIDDM patients with albuminuria (15-200 micrograms/min) were randomized into an 8-month-long therapy with either nitrendipine (n = 11) or enalapril (n = 10)." | 5.08 | Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients. ( Hwang, DL; Josefsberg, Z; Lev-Ran, A; Ross, SA, 1995) |
"A trial to study the efficacy, safety and tolerability of nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria (MA) was performed to compare the effects of both drugs in the prevention of the renal impairment." | 5.08 | Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria. ( Cases, A; Closas, J; Cobos, A; Esmatges, E; Pascual, R; Piñol, C; Planas, J; Soler, J, 1996) |
"To evaluate the efficacy and tolerability of nitrendipine in comparison with captopril in hypertensive diabetic patients with left ventricular hypertrophy (LVH)." | 5.08 | Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients. ( Carraro, A; Crepaldi, G; Fasoli, G; Frigato, F; Marin, M; Nisti, S; Nosadini, R; Palisi, M; Scognamiglio, R; Virgili, F, 1997) |
"To compare the effects of a calcium antagonist (nitrendipine) and an angiotensin converting enzyme inhibitor (enalapril) with those of placebo on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension." | 5.08 | Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension. ( Bak, AA; Gerritsen, TA; Grobbee, DE; Jonker, JJ; Stolk, RP, 1998) |
"The effect of short- (98 days) and long-term (1 year) treatment with nitrendipine (10 to 40 mg/d) and enalapril (5 to 20 mg/d) on kidney function was studied prospectively in a parallel group design in 16 microalbuminuric non-insulin-dependent diabetic patients with mild hypertension and biopsy-proven diabetic glomerulopathy." | 5.07 | Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. ( Bianchi, L; Campana, M; Cortesi, L; Mecca, G; Mosconi, L; Pagani, G; Remuzzi, G; Ruggenenti, P, 1994) |
" We have investigated whether long-term monotherapy with a calcium antagonist, nitrendipine, prevents the development of overt diabetic nephropathy in type I and type II diabetic patients with mild to moderate hypertension and persistent microalbuminuria (ie, incipient nephropathy)." | 3.68 | Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients. ( Bollen, CC; Bretzel, RG; Federlin, KF; Maeser, E, 1993) |
"The antihypertensive effect of nitrendipine, 20 mg once daily was studied in 30 patients with mild or moderate hypertension and type II diabetes mellitus under metabolic control." | 3.68 | Effect of nitrendipine in mild or moderate essential hypertensive subjects with type II diabetes. ( Casale, P; Papalia, D, 1991) |
"We investigated renal hemodynamics and fractional clearance of neutral dextrans of graded sizes, in nine proteinuric patients with NIDDM and renal biopsy findings of typical diabetic glomerulopathy." | 2.69 | Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade. ( Casiraghi, F; Gambara, V; Mosconi, L; Remuzzi, A; Remuzzi, G; Ruggenenti, P; Sangalli, F, 1999) |
"We report a case of type 2 diabetes mellitus presenting hypothyroidism due to overeating of seaweed that was noticed as a result of a discrepancy between glycated albumin (GA) and glycated hemoglobin (GHb)." | 1.33 | A case of type 2 diabetes mellitus developing hypothyroidism discovered as a result of a discrepancy between glycated hemoglobin and glycated albumin values. ( Arai, H; Hataya, Y; Hosoda, K; Kanamoto, N; Moriyama, K; Nakao, K; Nanbu, T, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (90.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moriyama, K | 1 |
Kanamoto, N | 1 |
Hataya, Y | 1 |
Nanbu, T | 1 |
Hosoda, K | 1 |
Arai, H | 1 |
Nakao, K | 1 |
Czupryniak, L | 1 |
Pawłowski, M | 1 |
Saryusz-Wolska, M | 1 |
Loba, J | 1 |
Fogari, R | 2 |
Zoppi, A | 2 |
Pasotti, C | 1 |
Mugellini, A | 2 |
Lusardi, P | 2 |
Lazzari, P | 2 |
Corradi, L | 2 |
Ruggenenti, P | 3 |
Mosconi, L | 3 |
Bianchi, L | 1 |
Cortesi, L | 1 |
Campana, M | 1 |
Pagani, G | 1 |
Mecca, G | 2 |
Remuzzi, G | 3 |
Giugliano, D | 1 |
De Rosa, N | 1 |
Marfella, R | 1 |
Di Maro, G | 1 |
Cacciapuoti, F | 1 |
Quatraro, A | 1 |
Acampora, R | 1 |
D'Onofrio, F | 1 |
Bretzel, RG | 1 |
Bollen, CC | 1 |
Maeser, E | 1 |
Federlin, KF | 1 |
Chan, JC | 1 |
Cockram, CS | 1 |
Nicholls, MG | 1 |
Josefsberg, Z | 1 |
Ross, SA | 1 |
Lev-Ran, A | 1 |
Hwang, DL | 1 |
Kato, S | 1 |
Ishida, H | 1 |
Tsuura, Y | 1 |
Tsuji, K | 1 |
Nishimura, M | 1 |
Horie, M | 1 |
Taminato, T | 1 |
Ikehara, S | 1 |
Odaka, H | 1 |
Ikeda, I | 1 |
Okada, Y | 1 |
Seino, Y | 1 |
Piñol, C | 1 |
Cobos, A | 1 |
Cases, A | 1 |
Esmatges, E | 1 |
Soler, J | 1 |
Closas, J | 1 |
Pascual, R | 1 |
Planas, J | 1 |
Perna, A | 1 |
Scognamiglio, R | 1 |
Nosadini, R | 1 |
Marin, M | 1 |
Nisti, S | 1 |
Fasoli, G | 1 |
Palisi, M | 1 |
Frigato, F | 1 |
Virgili, F | 1 |
Carraro, A | 1 |
Crepaldi, G | 1 |
Gerritsen, TA | 1 |
Bak, AA | 1 |
Stolk, RP | 1 |
Jonker, JJ | 1 |
Grobbee, DE | 1 |
Preti, P | 1 |
Sangalli, F | 1 |
Casiraghi, F | 1 |
Gambara, V | 1 |
Remuzzi, A | 1 |
Giuntoli, F | 1 |
Galeone, F | 1 |
Natali, A | 1 |
Gabbani, S | 1 |
Saba, P | 1 |
Papalia, D | 1 |
Casale, P | 1 |
Dolben, J | 1 |
Vora, J | 1 |
Smith, H | 1 |
Luzio, S | 1 |
Griffiths, D | 1 |
Vølund, A | 1 |
Owens, DR | 1 |
Tschöpe, D | 1 |
Rösen, P | 1 |
Gries, FA | 1 |
Gregorio, F | 1 |
Dini, FL | 1 |
Ambrosi, F | 1 |
Cristallini, S | 1 |
Pedetti, M | 1 |
Filipponi, P | 1 |
14 trials available for nitrendipine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Circadian Rhythm; Diab | 2007 |
Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal function.
Topics: Aged; Albuminuria; Analysis of Variance; Confidence Intervals; Creatinine; Diabetes Mellitus, Type 2 | 1995 |
Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients.
Topics: Adult; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enalapri | 1994 |
Comparison of nitrendipine and cilazapril in patients with hypertension and non-insulin-dependent diabetes mellitus.
Topics: Blood Pressure; Cilazapril; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blin | 1993 |
Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomark | 1995 |
Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; C | 1996 |
Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Calcium Channel Blocker | 1996 |
Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channe | 1997 |
Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Enala | 1998 |
Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Creatinine; D | 1999 |
Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cas | 1999 |
Antihypertensive and metabolic effects of nitrendipine in non-insulin-dependent diabetes mellitus with hypertension.
Topics: Aged; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Female; Humans; Hyperte | 1992 |
Nitrendipine once or twice daily in hypertensive non-insulin-dependent diabetes mellitus.
Topics: Aged; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administra | 1991 |
[Antihypertensive efficacy of nitrendipine and its effects on carbohydrate metabolism. A controlled clinical study versus placebo].
Topics: Aged; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyper | 1991 |
6 other studies available for nitrendipine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
A case of type 2 diabetes mellitus developing hypothyroidism discovered as a result of a discrepancy between glycated hemoglobin and glycated albumin values.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Cell Count; Diabetes Mellitus, Type 2; Diet; Female; G | 2006 |
Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients.
Topics: Albuminuria; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic N | 1993 |
Comparison of ramipril and nitrendipine.
Topics: Albuminuria; Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Nitrendipine; | 1995 |
Alterations in basal and glucose-stimulated voltage-dependent Ca2+ channel activities in pancreatic beta cells of non-insulin-dependent diabetes mellitus GK rats.
Topics: Animals; Calcium; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Diabetes Mellitus, Ty | 1996 |
Effect of nitrendipine in mild or moderate essential hypertensive subjects with type II diabetes.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Rate; Humans; Hypertension; Male; Mid | 1991 |
Increase in the cytosolic concentration of calcium in platelets of diabetics type II.
Topics: Aged; Blood Platelets; Calcium; Collagen; Cytosol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; | 1991 |